Literature DB >> 33453438

Toward sustainable, cell-free biomanufacturing.

Blake J Rasor1, Bastian Vögeli1, Grant M Landwehr1, Jonathan W Bogart1, Ashty S Karim2, Michael C Jewett3.   

Abstract

Industrial biotechnology is an attractive approach to address the need for low-cost fuels and products from sustainable resources. Unfortunately, cells impose inherent limitations on the effective synthesis and release of target products. One key constraint is that cellular survival objectives often work against the production objectives of biochemical engineers. Additionally, industrial strains release CO2 and struggle to utilize sustainable, potentially profitable feedstocks. Cell-free biotechnology, which uses biological machinery harvested from cells, can address these challenges with advantages including: (i) shorter development times, (ii) higher volumetric production rates, and (iii) tolerance to otherwise toxic molecules. In this review, we highlight recent advances in cell-free technologies toward the production of non-protein products beyond lab-scale demonstrations and describe guiding principles for designing cell-free systems. Specifically, we discuss carbon and energy sources, reaction homeostasis, and scale-up. Expanding the scope of cell-free biomanufacturing practice could enable innovative approaches for the industrial production of green chemicals.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 33453438     DOI: 10.1016/j.copbio.2020.12.012

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  8 in total

1.  Cell-Free Protein Synthesis for High-Throughput Biosynthetic Pathway Prototyping.

Authors:  Blake J Rasor; Bastian Vögeli; Michael C Jewett; Ashty S Karim
Journal:  Methods Mol Biol       Date:  2022

2.  An efficient cell-free protein synthesis platform for producing proteins with pyrrolysine-based noncanonical amino acids.

Authors:  Arnaz Ranji Charna; Benjamin J Des Soye; Ioanni Ntai; Neil L Kelleher; Michael C Jewett
Journal:  Biotechnol J       Date:  2022-06-09       Impact factor: 5.726

3.  Cell-free prototyping enables implementation of optimized reverse β-oxidation pathways in heterotrophic and autotrophic bacteria.

Authors:  Bastian Vögeli; Luca Schulz; Shivani Garg; Katia Tarasava; James M Clomburg; Seung Hwan Lee; Aislinn Gonnot; Elamar Hakim Moully; Blaise R Kimmel; Loan Tran; Hunter Zeleznik; Steven D Brown; Sean D Simpson; Milan Mrksich; Ashty S Karim; Ramon Gonzalez; Michael Köpke; Michael C Jewett
Journal:  Nat Commun       Date:  2022-06-01       Impact factor: 17.694

4.  Improving cell-free glycoprotein synthesis by characterizing and enriching native membrane vesicles.

Authors:  Jasmine M Hershewe; Katherine F Warfel; Shaelyn M Iyer; Justin A Peruzzi; Claretta J Sullivan; Eric W Roth; Matthew P DeLisa; Neha P Kamat; Michael C Jewett
Journal:  Nat Commun       Date:  2021-04-22       Impact factor: 14.919

Review 5.  Toward bioproduction of oxo chemicals from C1 feedstocks using isobutyraldehyde as an example.

Authors:  Liwei Guo; Lichao Sun; Yi-Xin Huo
Journal:  Biotechnol Biofuels Bioprod       Date:  2022-08-09

6.  Directed evolution of phosphite dehydrogenase to cycle noncanonical redox cofactors via universal growth selection platform.

Authors:  Linyue Zhang; Edward King; William B Black; Christian M Heckmann; Allison Wolder; Youtian Cui; Francis Nicklen; Justin B Siegel; Ray Luo; Caroline E Paul; Han Li
Journal:  Nat Commun       Date:  2022-08-26       Impact factor: 17.694

7.  In vivo, in vitro and in silico: an open space for the development of microbe-based applications of synthetic biology.

Authors:  Antoine Danchin
Journal:  Microb Biotechnol       Date:  2021-09-27       Impact factor: 5.813

Review 8.  Biotechnology Applications of Cell-Free Expression Systems.

Authors:  August Brookwell; Javin P Oza; Filippo Caschera
Journal:  Life (Basel)       Date:  2021-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.